Download
00402_2024_Article_5179.pdf 1,59MB
WeightNameValue
1000 Titel
  • Treatment of cartilage defects in the patellofemoral joint with matrix-associated autologous chondrocyte implantation effectively improves pain, function, and radiological outcomes after 5–7 years
1000 Autor/in
  1. Eichinger, Martin |
  2. Henninger, Benjamin |
  3. Petry, Benjamin |
  4. Schuster, Philipp |
  5. Herbst, Elmar |
  6. Wagner, Moritz |
  7. Rosenberger, Ralf |
  8. Mayr, Raul |
1000 Verlag Springer Berlin Heidelberg
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-01-11
1000 Erschienen in
1000 Quellenangabe
  • 144(4):1655-1665
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00402-023-05179-0 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10965587/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:sec> <jats:title>Introduction</jats:title> <jats:p>The aim of the present study was to evaluate midterm outcomes 5–7 years after matrix-associated autologous chondrocyte implantation (MACI) in the patellofemoral joint.</jats:p> </jats:sec><jats:sec> <jats:title>Materials and methods</jats:title> <jats:p>Twenty-six patients who had undergone MACI using the Novocart® 3D scaffold were prospectively evaluated. Clinical outcomes were determined by measuring the 36-Item Short-Form Health Survey (SF-36) and International Knee Documentation Committee (IKDC) scores and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) values preoperatively and 3, 6, and 12 months, and a mean of 6 years postoperatively. At the final follow-up, the Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART) score was evaluated.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>Twenty-two patients with 23 focal cartilage defects (19 patella and four trochlea) were available for the final follow-up. The mean defect size was 4.0 ± 1.9 cm<jats:sup>2</jats:sup> (range 2.4–9.4 cm<jats:sup>2</jats:sup>). All clinical outcome scores improved significantly until 5–7 years after MACI (SF-36 score, 61.2 ± 19.6 to 83.2 ± 11.6; <jats:italic>P</jats:italic> = 0.001; IKDC score, 47.5 ± 20.6 to 74.7 ± 15.5; <jats:italic>P</jats:italic> &lt; 0.001; and WOMAC, 29.8 ± 15.7 to 8.2 ± 10.3; <jats:italic>P</jats:italic> &lt; 0.001). The mean MOCART score was 76.0 ± 11.0 at the final follow-up. Nineteen of the 22 patients (86.4%) were satisfied with the outcomes after 5–7 years and responded that they would undergo the procedure again.</jats:p> </jats:sec><jats:sec> <jats:title>Conclusion</jats:title> <jats:p>MACI in the patellofemoral joint demonstrated good midterm clinical results with a significant reduction in pain, improvement in function, and high patient satisfaction. These clinical findings are supported by radiological evidence from MOCART scores.</jats:p> </jats:sec><jats:sec> <jats:title>Level of evidence</jats:title> <jats:p>IV–case series.</jats:p> </jats:sec>
1000 Sacherschließung
lokal Patellofemoral Joint/surgery [MeSH]
lokal Follow-Up Studies [MeSH]
lokal Knee Injuries/surgery [MeSH]
lokal Humans [MeSH]
lokal Cartilage, Articular/diagnostic imaging [MeSH]
lokal Knee Joint/surgery [MeSH]
lokal Arthroscopy and Sports Medicine
lokal Patellofemoral joint
lokal Magnetic Resonance Imaging [MeSH]
lokal Magnetic resonance observation of cartilage repair tissue score
lokal Pain [MeSH]
lokal Cartilage, Articular/surgery [MeSH]
lokal Matrix-associated autologous chondrocyte implantation
lokal Transplantation, Autologous/methods [MeSH]
lokal Cartilage Diseases/surgery [MeSH]
lokal Clinical outcomes
lokal Patellofemoral Joint/diagnostic imaging [MeSH]
lokal Cartilage
lokal Chondral defect
lokal Chondrocytes [MeSH]
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/RWljaGluZ2VyLCBNYXJ0aW4=|https://frl.publisso.de/adhoc/uri/SGVubmluZ2VyLCBCZW5qYW1pbg==|https://frl.publisso.de/adhoc/uri/UGV0cnksIEJlbmphbWlu|https://frl.publisso.de/adhoc/uri/U2NodXN0ZXIsIFBoaWxpcHA=|https://frl.publisso.de/adhoc/uri/SGVyYnN0LCBFbG1hcg==|https://frl.publisso.de/adhoc/uri/V2FnbmVyLCBNb3JpdHo=|https://frl.publisso.de/adhoc/uri/Um9zZW5iZXJnZXIsIFJhbGY=|https://frl.publisso.de/adhoc/uri/TWF5ciwgUmF1bA==
1000 Hinweis
  • DeepGreen-ID: f27bef13973e4242b2e80f4113e9673b ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search) ;
1000 Label
1000 Förderer
  1. University of Innsbruck and Medical University of Innsbruck |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer University of Innsbruck and Medical University of Innsbruck |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6521331.rdf
1000 Erstellt am 2025-07-06T07:14:00.431+0200
1000 Erstellt von 322
1000 beschreibt frl:6521331
1000 Zuletzt bearbeitet 2025-08-04T09:54:21.468+0200
1000 Objekt bearb. Mon Aug 04 09:54:21 CEST 2025
1000 Vgl. frl:6521331
1000 Oai Id
  1. oai:frl.publisso.de:frl:6521331 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source